BioCentury
ARTICLE | Financial News

Seattle Genetics prices $690M follow-on

February 2, 2018 8:35 PM UTC

Seattle Genetics Inc. (NASDAQ:SGEN) raised $690 million through the sale of 13.3 million shares at $52 in a bumped-up follow-on underwritten by Barclays and J.P. Morgan. The figures include the sale of a 1.7 million share overallotment on Feb. 2. The price is a 6% discount to Seattle Genetics' close of $55.21 on Jan. 30, the day before the offering was announced...